Hillyard Alcohol Free Foaming Instant Hand Sanitizer Liquid
FDA Recall NDC 76402-403
FDA Enforcement Report: View Recall Date, Reasons, and Safety Status
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Hillyard Alcohol Free Foaming Instant Hand Sanitizer (NDC 76402-403). A significant event, classified as Class II, was initiated on Dec 28, 2012 by Hillyard Gmp. The reported reason for this action was: "Microbial Contamination of Non-Sterile Products: The product may be contaminated with bacteria."
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of TERMINATED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
December 2012 Class II Recall: Microbial Contamination of Non-Sterile Products
Recall Number
Class II Terminated
Microbial Contamination of Non-Sterile Products: The product may be contaminated with bacteria.
Dec 28, 2012
Feb 06, 2013
2,139 bottles
Recall Profile & Regulatory Data
Event ID
64020
Classification
Class II
Enforcement Status
Terminated
Recalling Firm
Hillyard GMP
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Distribution nationwide
Termination Date
Jan 29, 2014
Product Description
HILLYARD, Alcohol Free Foaming Instant Hand Sanitizer, Benzalkonium Chloride 0.10%, 1.25 L plastic bottle, OTC, HILLYARD IDUSTRIES, St. Joseph, MO. 64502 NDC 76402-403-03
Batch or Lot Expiration Information
Lot# Lot 1025554, Exp: 03/14 and Lot 1030652, Exp: 09/14
Affected Packages Involved in this Recall
76402-403-06Product
76402-403-03Product
76402-403-02Product
76402-403-82Product
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
